Tech Company Financing Transactions
Beacon Biosignals Funding Round
Beacon Biosignals closed a $86 million Series B funding round on 11/13/2025. Backers included Casdin Capital, Catalio Capital Management and General Catalyst.
Transaction Overview
Company Name
Announced On
11/13/2025
Transaction Type
Venture Equity
Amount
$86,000,000
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds to scale its technology and operations to accelerate neurobiomarker discovery and broaden clinical adoption.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
80 Revere St. 10
Boston, MA 02114
USA
Boston, MA 02114
USA
Phone
Undisclosed
Website
Email Address
Overview
Beacon's machine learning platform for EEG enables and accelerates new treatments that transform the lives of patients with neurological, psychiatric or sleep disorders. Through novel machine learning algorithms, large datasets, and advances in software engineering, Beacon Biosignals is changing the way patients are treated for disorders of the brain.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jacob Donoghue
Chief Technical Officer
Jarrett Revels
Co-Founder
Sydney Cash
Co-Founder
Brandon Westover
Browse more venture capital transactions:
Prev: 11/13/2025: Fabric8Labs venture capital transaction
Next: 11/13/2025: Exowatt venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on tech company VC transactions. VC investment data records reported here come from company press releases and news coverage. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs